Blog

32 Articles

altered photo of bottles in teal and aqua
Research
May 2, 2023 • 2 Min

Chemo and SBRT for Inoperable Pancreatic Cancer

For inoperable pancreatic cancer, researchers are comparing mFOLFIRINOX and SBRT with gemcitabine-based treatment regimens.

slide of pancreatic cells in bright colors
Research
October 4, 2022 • 2 Min

More Effective Radiotherapy for Advanced Pancreatic Cancer Patients

Researchers are testing a drug that penetrates the stroma, to make radiotherapy work better for advanced pancreatic cancer patients.

pills in gray scale
Research
July 19, 2022 • 2 Min

Four-Drug Combination Tested in Metastatic Pancreatic Cancer

A clinical trial is testing a drug combination including a drug used for erectile dysfunction, a new drug, and two immunotherapy drugs.

black and white photo of DNA reading
Research
March 11, 2022 • 2 Min

Testing an Approved Drug for a Specific Mutation

Researchers are testing a drug combination for melanoma in pancreatic cancer patients with a BRAF genetic mutation.

pancreatic cancer patient Michael Francis in a field of roses
Survivor Stories
February 17, 2021 • 3 Min

Time and Hope

Rose farmer Michael Francis wanted more time with his family, so he joined a clinical trial to treat his stage III pancreatic cancer.

microscope image of zebrafish scales in blues and greens
Research
September 22, 2020 • 2 Min

Safety and Effectiveness of a New Drug for Advanced Pancreatic Cancer

Researchers are testing dose safety and effectiveness of a new drug for pancreatic cancer, in combination with gemcitabine.

Chemistry tubes with purple, yellow and white liquids in a red rack
Research
July 31, 2020 • 3 Min

Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer

This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.

red tops and black tops of new beakers against a silver background
Research
June 11, 2020 • 3 Min

Chemotherapy Plus Minimally Invasive Surgery for Pancreatic Cancer

Researchers want to know if irreversible electroporation (IRE) makes it easier for chemotherapy to reach pancreatic cancer cells.

The tops of closed lab vials as seen from overhead against a blue-ish background
Research
March 26, 2020 • 2 Min

Combining Two Drugs with Different Approaches to Enhance Treatment

A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.

DNA helix made of metal, plastic and stained glass
Research
January 10, 2020 • 2 Min

Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers

Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.

A yellow paper model of DNA helix against a dark background
Research
July 11, 2019 • 2 Min

Immunotherapy to Attack a Common Pancreatic Cancer Mutation

Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.

a hand holding a petri dish in a lab, in black and white
Research
April 24, 2019 • 2 Min

Immunotherapy for Advanced Pancreatic Cancer and Other Solid Tumors

Researchers are testing the use of tumor-infiltrating lymphocytes, a type of immunotherapy, against advanced pancreatic cancer.

electron microscope image of concentric circles formed by reactive ion etching
Research
March 29, 2019 • 2 Min

Immunotherapy to Enhance Standard Chemotherapy for Advanced Pancreatic Cancer

Researchers are testing an immunotherapy drug approved for other advanced cancers for effectiveness against pancreatic cancer.

multicolor abstract computer created image of series of squares that look like a DNA helix
Research
February 7, 2019 • 2 Min

Testing a Different Approach to Pancreatic Cancer Treatment

A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.

Pancreatic cancer survivor Richard Blish and his wife Marian at their wedding
Survivor Stories
December 7, 2018 • 3 Min

The Positive Impact of a Pancreatic Cancer Clinical Trial

Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.